Nisa Investment Advisors LLC increased its stake in shares of DaVita Inc. (NYSE:DVA – Free Report) by 26.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,694 shares of the company’s stock after buying an additional 7,752 shares during the quarter. Nisa Investment Advisors LLC’s holdings in DaVita were worth $5,085,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of DaVita by 2.4% during the fourth quarter. Vanguard Group Inc. now owns 6,320,740 shares of the company’s stock valued at $662,161,000 after buying an additional 145,711 shares during the last quarter. Gates Capital Management Inc. grew its holdings in shares of DaVita by 3.1% during the fourth quarter. Gates Capital Management Inc. now owns 905,830 shares of the company’s stock valued at $94,895,000 after buying an additional 27,660 shares during the last quarter. 8 Knots Management LLC purchased a new stake in shares of DaVita during the fourth quarter valued at $89,504,000. Allianz Asset Management GmbH grew its holdings in shares of DaVita by 63.9% during the fourth quarter. Allianz Asset Management GmbH now owns 548,642 shares of the company’s stock valued at $57,476,000 after buying an additional 213,992 shares during the last quarter. Finally, Doma Perpetual Capital Management LLC purchased a new stake in DaVita in the fourth quarter valued at $53,076,000. 90.12% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at DaVita
In related news, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the completion of the sale, the insider now owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the completion of the sale, the insider now owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, COO Michael David Staffieri sold 9,539 shares of the company’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the sale, the chief operating officer now directly owns 241,945 shares of the company’s stock, valued at approximately $36,299,008.35. The disclosure for this sale can be found here. 2.00% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on DVA
DaVita Stock Up 1.2 %
DVA opened at $152.17 on Tuesday. DaVita Inc. has a twelve month low of $71.51 and a twelve month high of $152.22. The company has a quick ratio of 1.12, a current ratio of 1.16 and a debt-to-equity ratio of 9.94. The company has a 50-day moving average price of $140.53 and a 200 day moving average price of $135.42. The company has a market cap of $13.35 billion, a PE ratio of 17.29, a price-to-earnings-growth ratio of 0.86 and a beta of 0.87.
DaVita (NYSE:DVA – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.47 by $0.12. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.15 billion. During the same quarter in the prior year, the firm earned $2.08 EPS. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. Sell-side analysts expect that DaVita Inc. will post 9.9 earnings per share for the current fiscal year.
About DaVita
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Read More
- Five stocks we like better than DaVita
- The Risks of Owning Bonds
- Merck’s Stock Dip Offers a Buying Opportunity: Here’s Why
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Stocks with Surging Call Option Volume in the Recovery Rally
- How to buy stock: A step-by-step guide for beginners
- 3 High P/E Stocks That Are Still Worth Buying Right Now
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.